nach oben

Erschienen in:

30.03.2020 | Breast Oncology

Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?

verfasst von: Bryan J. Pyfer, MD, MBA, Michael Jonczyk, MD, Jolie Jean, BS, Roger A. Graham, MD, Lilian Chen, MD, Abhishek Chatterjee, MD, MBA

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

For patients with ductal carcinoma in situ (DCIS), multiple national cancer organizations recommend that sentinel lymph node biopsy (SLNB) be offered when treated with mastectomy, but not when treated with breast-conserving surgery (BCS). This study analyzes national surgical trends of SLNB and axillary lymph node dissection (ALND) in DCIS patients undergoing breast surgery with the aim to quantify deviations from national guidelines.

Methods

A retrospective cohort analysis of the American College of Surgeons’ National Surgical Quality Improvement Program (ACS NSQIP) database from 2005 to 2017 identified patients with DCIS. Patients were categorized by their primary method of breast surgery, i.e. mastectomy or BCS, then further categorized by their axillary lymph node (ALN) management, i.e. no intervention, SLNB, or ALND. Data analysis was conducted via linear regression and a non-parametric Mann–Kendall test to assess a temporal trend and Sen’s slope.

Results

Overall, 43,448 patients with DCIS met the inclusion criteria: 20,504 underwent mastectomy and 22,944 underwent BCS. Analysis of DCIS patients from 2005 to 2017 revealed that ALND decreased and SLNB increased in every subgroup, regardless of surgical treatment modality. Evaluation in the mastectomy group increased overall: mastectomy alone increased from 57.1 to 65.8% (p < 0.01) and mastectomy with immediate reconstruction increased from 58.5 to 72.1% (p < 0.01). Increases also occurred in the total BCS population: partial mastectomy increased from 14.0 to 21.1% and oncoplastic surgery increased from 10.5 to 23.0% (both p < 0.01).

Conclusions

Despite national guideline recommendations for the management of ALN surgery in DCIS patients, approximately 20–30% of cases continue to not follow these guidelines. This warrants further education for surgeons and patients.

Tanis PJ, Nieweg OE, Valdes Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res. 2001;3(2):109–12.PubMedPubMedCentralCrossRef

Jacobson JA, Danforth DN, Cowan KH, d’Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332(14):907–11.PubMedCrossRef

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.PubMedCrossRef

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med. 2002;347(16):1233–41.PubMedCrossRef

Kelsall JE, McCulley SJ, Brock L, Akerlund MTE, Macmillan RD. Comparing oncoplastic breast conserving surgery with mastectomy and immediate breast reconstruction: case-matched patient reported outcomes. J Plast Reconstr Aesthet Surg. 2017;70(10):1377–1385PubMedCrossRef

Chatterjee A, Serniak N, Czerniecki BJ. Sentinel lymph node biopsy in breast cancer: a work in progress. Cancer J. 2015;21(1):7.CrossRefPubMed

Mitchell KB, Lin H, Shen Y, Colfry A, Kuerer H, Shaitelman SF, et al. DCIS and axillary nodal evaluation: compliance with national guidelines. BMC Surg. 2017;17(1):12.PubMedPubMedCentralCrossRef

Shah DR, Canter RJ, Khatri VP, Bold RJ, Yang AD, Martinez SR. Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol. 2013;20(1):24–30.PubMedCrossRef

Killelea BK, Long JB, Dang W, Mougalian SS, Evans SB, Gross CP, et al. Associations between sentinel lymph node biopsy and complications for patients with ductal carcinoma in situ. Ann Surg Oncol. 2018;25(6):1521–9.PubMedPubMedCentralCrossRef

10.

Pyfer B, Chatterjee A, Chen L, Nigriny J, Czerniecki B, Tchou J, et al. Early postoperative outcomes in breast conservation surgery versus simple mastectomy with implant reconstruction: a NSQIP analysis of 11,645 patients. Ann Surg Oncol. 2016;23(1):92–8.PubMedCrossRef

11.

Mattingly AE, Ma Z, Smith PD, Kiluk JV, Khakpour N, Hoover SJ, et al. Early postoperative complications after oncoplastic reduction. Southern Med J. 2017;110(10):660–6.PubMedCrossRefPubMedCentral

12.

Jonczyk MM, Jean J, Graham R, Chatterjee A. Trending towards safer breast cancer surgeries? Examining acute complication rates from a 13-year NSQIP analysis. Cancers. 2019;11(2):253. https://doi.org/10.3390/cancers11020253.PubMedCentralCrossRef

13.

Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365–83.PubMedCrossRef

14.

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. Breast Cancer, Version 4.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(3):310–20.PubMedCrossRef

15.

Jonczyk MM, Jean J, Graham R, Chatterjee A. Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis. Breast Cancer Res Treat. 2019;173(2):267–274.PubMedCrossRef

16.

American College of Surgeons (ACS). ACS National Surgical Quality Improvement Program. Overview and description of ACS NSQIP database and participant user files. Chicago, IL: ACS; 2018.

17.

Losken A, Hart AM, Chatterjee A. Updated evidence on the oncoplastic approach to breast conservation therapy. Plast Reconstr Surg. 2017;140(5S Advances in Breast Reconstruction):14S–22S.PubMedCrossRef

18.

Chatterjee A, Gass J, Patel K, Holmes D, Kopkash K, Peiris L, et al. A consensus definition and classification system of oncoplastic surgery developed by the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(11):3436–3444.PubMedCrossRef

19.

American Cancer Society. Breast Cancer Facts & Figures 2017–2018: Atlanta, GA: American Cancer Society, Inc.; 2017. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf.

20.

Tada K, Ogiya A, Kimura K, Morizono H, Iijima K, Miyagi Y, et al. Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. World J Surg Oncol. 2010;8:6.PubMedPubMedCentralCrossRef

21.

Osako T, Iwase T, Ushijima M, Horii R, Fukami Y, Kimura K, et al. Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ. Cancer Sci. 2014;105(5):576–82.PubMedPubMedCentralCrossRef

22.

Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Chen L, et al. The influence of hospital and surgeon factors on the prevalence of axillary lymph node evaluation in ductal carcinoma in situ. JAMA Oncol. 2015;1(3):323–32.PubMedCrossRef

23.

Chatterjee A, Gass J, Burke MB, Kopkash K, El-Tamer MB, Holmes DR, et al. Results from the American Society of breast surgeons oncoplastic surgery committee 2017 survey: current practice and future directions. Ann Surg Oncol. 2018;25(10):2790–4.PubMedCrossRef

24.

Chatterjee A, Dayicioglu D, Khakpour N, Czerniecki BJ. Oncoplastic Surgery: Keeping it simple with 5 essential volume displacement techniques for breast conservation in a patient with moderate to large sized breasts. Cancer Control. 2017;24(4):1–11.CrossRef

25.

Skinner KA, Silberman H, Dougherty W, Gamagami P, Waisman J, Sposto R, et al. Breast cancer after augmentation mammoplasty. Ann Surg Oncol. 2001;8(2):138–44.PubMedCrossRef

26.

Miglioretti DL, Rutter CM, Geller BM, Cutter G, Barlow WE, Rosenberg R, et al. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA. 2004;291(4):442–50.PubMedCrossRef

27.

Silverstein MJ, Handel N, Gamagami P, Gierson ED, Furmanski M, Collins AR, et al. Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses. Eur J Cancer. 1992;28(2–3):635–40.PubMedCrossRef

28.

McCarten D, Gemignani ML. Current Management of the Axilla. Clin Obstet Gynecol. 2016;59(4):743–55.CrossRef

29.

Watanabe Y, Anan K, Saimura M, Koga K, Fujino M, Mine M, et al. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy. Breast Cancer. 2018;25(6):663–70.PubMedCrossRef

30.

Sakr R, Antoine M, Barranger E, Dubernard G, Salem C, Darai E, et al. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Breast J. 2008;14(1):55–60.PubMedCrossRef

31.

Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg. 2005;190(4):563–6.PubMedCrossRef

32.

Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone St, et al. A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease. Ann Surg Oncol. 2017;24(10):2915–24.

33.

Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8.PubMedCrossRef

34.

Valdes EK, Boolbol SK, Cohen JM, Feldman SM. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy? Ann Surg Oncol. 2007;14(3):1045–50.PubMedCrossRef

35.

Guidroz JA, Johnson MT, Scott-Conner CEH, De Young BR, Weigel RJ. The use of touch preparation for the evaluation of sentinel lymph nodes in breast cancer. Am J Surg. 2010;199(6):792–6.PubMedCrossRef

36.

Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg. 2007;94(8):952–6.PubMedCrossRef

37.

Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2008;196(1):81–7.PubMedPubMedCentralCrossRef

38.

Renshaw AA. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med. 2002;126(1):39–41.PubMed

39.

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305.PubMedPubMedCentralCrossRef

40.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.PubMedPubMedCentralCrossRef

41.

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33.PubMedPubMedCentralCrossRef

42.

Nocera NF, Pyfer BJ, De La Cruz LM, Chatterjee A, Thiruchelvam PT, Fisher CS. NSQIP analysis of axillary lymph node dissection rates for breast cancer: implications for resident and fellow participation. J Surg Educ. 2018;75(5):1281–6.PubMedCrossRef

43.

American College of Surgeons. User Guide for the 2017 ACS NSQIP participant use data file (PUF). October 2018.

Titel: Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
verfasst von: Bryan J. Pyfer, MD, MBA
Michael Jonczyk, MD
Jolie Jean, BS
Roger A. Graham, MD
Lilian Chen, MD
Abhishek Chatterjee, MD, MBA
Publikationsdatum: 30.03.2020
Verlag: Springer International Publishing
Erschienen in: Annals of Surgical Oncology / Ausgabe 9/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-020-08374-0

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?